Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05144633 · ClinicalTrials.gov registry record

Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)

A clinical trial of Acute Respiratory Failure, sponsored by University of Louisville.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT05144633 is a study of Acute Respiratory Failure that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 100 participants, below the 1,474-participant average among 13 other Acute Respiratory Failure trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05144633, a study of Acute Respiratory Failure, is actively recruiting participants, sponsored by University of Louisville.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

This is an observational study that will be enrolling University of Louisville patients who present to the Emergency Department in Acute Respiratory Failure. This study will be to determine if the addition of Eko AI-assisted lung auscultation examination to a standard of care Pulmonary POCUS + assists with acute respiratory failure diagnosis.

Conditions Studied

Interventions

  • DEVICE Auscultation

Study Locations (1)

Kentucky

  • University of Louisville - Louisville

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2021-09-09
Est. Completion 2025-04-30

Sponsor

University of Louisville

217 total trials

What the Registry Record Tells You About NCT05144633

The ClinicalTrials.gov registry entry for NCT05144633 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,474-participant average among 13 other Acute Respiratory Failure trials with a reported enrollment target (93% lower). The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Respiratory Failure appearing as the primary indexed condition, and to 1 intervention - of which Auscultation is the first listed.

NCT05144633 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT05144633 about?

NCT05144633 is a clinical study titled "Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)". This is an observational study that will be enrolling University of Louisville patients who present to the Emergency Department in Acute Respiratory Failure. This study will be to determine if the addition of Eko AI-assisted lung auscultation examination to a standard of care Pulmonary POCUS + assis...

What is the current status of trial NCT05144633?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2021-09-09. Estimated completion is 2025-04-30.

What conditions does trial NCT05144633 study?

This clinical trial studies the following conditions: Acute Respiratory Failure.

What interventions are being tested in trial NCT05144633?

The interventions under investigation include: Auscultation (DEVICE).

Who is sponsoring clinical trial NCT05144633?

This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05144633 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Respiratory Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.